Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	-95.26	-4.11	86.61
Graham Fair Price	inf	0.00	12.18
PEG	inf	0.00	1.48
Price/Book	inf	0.00	11.45
Price/Cash Flow	inf	0.00	96.42
Prices/Earnings	inf	0.00	27.96
Price/Sales	inf	0.00	37.00
Price/FCF	inf	0.00	96.42
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	0.97	0.67	0.67
Operating Margin	5.86	0.39	0.37
ROA	6.36	0.06	0.05
ROE	0.10	0.11	2.57
ROIC	0.07	0.08	8.46
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	< 0.005	< 0.005	0.24
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.16	0.15	-7.23
EPS QOQ	0.19	-1.00	430.77
FCF QOQ	0.32	0.02	-93.67
Revenue QOQ	0.06	0.08	40.98
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	98.18	90.60	-7.72
Days Sales Outstanding (DSO)	77.28	82.37	6.59
Inventory Turnover	0.92	0.99	8.36
Debt/Capitalization	0.32	0.29	-7.80
Quick Ratio	4.87	4.63	-5.02
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	8.02	0.00	inf
Cash	7.59	0.00	inf
Capex	-0.06	0.00	inf
Free Cash Flow	0.95	0.00	inf
Revenue	2.48	0.00	inf
Naive Interpretation	member

05 - Per Share Metrics · Not Interpreted

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	5.38	5.05	-6.11
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-3.82	-4.11	-7.59
Naive Interpretation	Member

06 - Financial Health · Bad

Rating